Vince & Associates Clinical Research, a premier provider of early phase
clinical research services, today announced it has added facial
recognition software as an additional security feature to its pharmacy.
The new system scans over 2,000 points of a user's face multiple times
each second and can track the identity of each person who is scanned
including the limited key individuals authorized access as well as the
identity of those denied access.
Dr. Brad Vince, CEO and Medical Director of Vince & Associates, states,
"Vince & Associates conducts a large number of clinical trials with
controlled substances. In order to ensure the highest level of security
with these drug materials, this advanced biometric security system has
been implemented in addition to existing security controls."
"As technology advances, we look to implement more sophisticated
safeguards for the security measures of controlled substances. The
proprietary identification algorithms and interface software of this new
system have had years of rigorous field testing," said Scott Smiley,
Director of Pharmacy Operations.
Vince & Associates Clinical Research early development center incudes a
pharmacy with full-time clinical research pharmacists. The Pharmacists
have extensive knowledge and experience in preparing and dosing studies
via oral, sublingual, intranasal and parenteral routes.
The pharmacy has a USP 797 certified clean room with Class II Biological
Safety Cabinet and is set up with a negative pressure, HEPA filtered
extemporaneous compounding room equipped with PowderSafe Ductless
Balance Enclosure. The pharmacy is essential to the Vince & Associates
clinical pharmacology unit and is capable of supporting the dispensing
for a wide range of Phase I/IIa studies in both in healthy normal
volunteers and special populations.
About Vince & Associates Clinical Research
Vince & Associates Clinical Research has provided clinical research
services to the biopharmaceutical industry for nearly 15 years. The
research professionals at Vince & Associates are proud to be recognized
in the industry as a "Center of Research Excellence."
Vince & Associates currently operates a state-of-the-art,
multimillion-dollar, 90-bed clinical pharmacology unit that combines the
ultimate in subject safety and luxury. This early development unit has
the upscale atmosphere necessary for the recruitment and retention of
study volunteers in both short- and long-term clinical trials. From the
safety and security of the controlled access unit to the added features
of a movie theater and game rooms, no detail has been overlooked.
Altasciences is the parent company of wholly owned subsidiaries Vince &
Associates Clinical Research (Kansas, USA) and Algorithme Pharma
(Quebec, Canada). Both organizations provide comprehensive early stage
clinical services in Phase I/IIa, including the necessary support
services in this critical stage of drug development.
Additional background materials pertaining to Vince & Associates
Clinical Research are located on the corporate website at www.vinceandassociates.com.
[ Back To NFVZone's Homepage ]